Skip to main content

Table 2 Direct-acting antiviral drug registration in surveyed countries (September 2016)

From: Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries

Country sofosbuvir sofosbuvir generic sofosbuvir/ ledipasvir sofosbuvir/ ledipasvir generic daclatasvir daclatasvir generic ombitasvir/ paritaprevir/ ritonavir/ dasabuvir (Viekira Pak) ombitasvir/ paritaprevir/ ritonavir dasabuvir simeprevir asunaprevir narlaprevir boceprivir telaprevir
Armenia              Yes Yes
Azerbaijan   Yes     pending Yes       Yes Yes
Belarus        Yes       Yes Yes
Georgia Yes   Yes    pending        Yes Yes
Kazakhstan    pending     Yes    Yes    Yes Yes
Kyrgyzstan   Yes Yes Yes   pending         
Moldova   Yes       Yes Yes Yes    Yes Yes
Russia Yes     Yes   Yes    Yes Yes Yes Yes Yes
Tajikistan   Yes             
Ukraine Yes Yes Yes    pending Yes Yes Yes Yes    Yes Yes
Uzbekistan   Yes         humanitarian    Yes